J. Goldman & CO LP Collegium Pharmaceutical, Inc Call Options Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
Call Options
1 transactions
Others Institutions Holding COLL
# of Institutions
252Shares Held
37.5MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$179 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$81.2 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$72.3 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$66 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$51 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.05B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...